Barbara Ann Karmanos Cancer Institute

12/20/2024 | Press release | Archived content

IN THE NEWS: Karmanos Institute 1st to Treat Liver Cancer with At-Home Device

December 20, 2024

Becker's Hospital Review

The Barbara Ann Karmanos Cancer Institute is the first in the world to prescribe the TheraBionic P1 device, an at-home treatment for adults with advanced liver cancer. The device was approved by the FDA in September 2023 for adult patients who have failed first- and second-line treatments.

Read the article here.

Click here to learn more about the TheraBonic P1 device.

Barbara Ann Karmanos Cancer Institute published this content on December 20, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 07, 2025 at 13:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]